| 000 | 01131 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512163654.0 | ||
| 264 | 0 | _c19710211 | |
| 008 | 197102s 0 0 eng d | ||
| 022 | _a0001-5822 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSelye, H | |
| 245 | 0 | 0 |
_aRole of the liver in the prevention of indomethacin-induced intestinal ulcers by spironolactone. _h[electronic resource] |
| 260 |
_bActa hepato-splenologica _c |
||
| 300 |
_a393-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDihydrotachysterol |
| 650 | 0 | 4 | _aDrug Antagonism |
| 650 | 0 | 4 | _aEnzyme Induction |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHepatectomy |
| 650 | 0 | 4 | _aIndomethacin |
| 650 | 0 | 4 |
_aIntestinal Diseases _xchemically induced |
| 650 | 0 | 4 |
_aIntestinal Perforation _xchemically induced |
| 650 | 0 | 4 |
_aLiver _xphysiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrosomes, Liver |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSpironolactone _xpharmacology |
| 650 | 0 | 4 | _aStimulation, Chemical |
| 650 | 0 | 4 |
_aUlcer _xchemically induced |
| 773 | 0 |
_tActa hepato-splenologica _gvol. 17 _gno. 6 _gp. 393-7 |
|
| 999 |
_c5491752 _d5491752 |
||